Annette Carmichael, Emily Orr, Alejandro Cisneros-Orozco, Kevin O. Rynn, Kristine Zimmermann
{"title":"Pilot of interactive texting for diabetes self-management education and support","authors":"Annette Carmichael, Emily Orr, Alejandro Cisneros-Orozco, Kevin O. Rynn, Kristine Zimmermann","doi":"10.1016/j.japh.2025.102403","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Controlling type 2 diabetes requires medication adherence, monitoring blood sugar, weight management, and dietary and physical activity behaviors. Estimates link a 1% reduction in hemoglobin A1c (HbA1c) to up to a 40% decrease in complications. Accessible supports for self-management behaviors can help increase adherence and lower HbA1c. However, uninsured and low-income populations may experience unique self-management challenges and have limited access to self-management supports.</div></div><div><h3>Objectives</h3><div>To assess the feasibility, acceptability, and preliminary effectiveness of a pharmacist-driven 6-month pilot intervention to support diabetes self-management behaviors utilizing text messages among uninsured and underinsured patients with uncontrolled diabetes.</div></div><div><h3>Methods</h3><div>Eligible participants were English or Spanish-speaking patients at a Federally Qualified Health Center in Northern Illinois who had poorly controlled type 2 diabetes (HbA1c > 7) and access to a smartphone. Participants' HbA1c was measured at enrollment and upon completion. Interactive and informational messages were sent to participants using a secure text-messaging application. Messages included explanations, encouragement, and problem-solving suggestions. Message frequency was tapered to withdraw support gradually. Message engagement was tracked within the text-messaging software.</div></div><div><h3>Results</h3><div>Electronic medical records identified 192 eligible patients with type 2 diabetes, of whom 76 consented to enroll in the intervention. Mean HbA1c at enrollment was 9.3%. Engagement with messages did not vary by demographic or clinical characteristics. Of 75 participants in the analytic sample, 60 completed the postintervention HbA1c measurement. Thirty-five (58.3%) had clinically significant reductions in their HbA1c, and 16 (26.7%) reduced their HbA1c to under 7%, which is considered controlled. Smaller groups saw either HbA1c decreases of less than 0.5% (n = 8, 13.3%), no change (n = 3, 5.0%), or increases (n = 14, 23.3%).</div></div><div><h3>Conclusion</h3><div>This feasible and low-cost pilot intervention utilizing pharmacist services helped a large portion of patients attain a clinically significant reduction in their HbA1c and contributed to some individuals achieving blood sugar control.</div></div>","PeriodicalId":50015,"journal":{"name":"Journal of the American Pharmacists Association","volume":"65 4","pages":"Article 102403"},"PeriodicalIF":2.5000,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American Pharmacists Association","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1544319125000822","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Controlling type 2 diabetes requires medication adherence, monitoring blood sugar, weight management, and dietary and physical activity behaviors. Estimates link a 1% reduction in hemoglobin A1c (HbA1c) to up to a 40% decrease in complications. Accessible supports for self-management behaviors can help increase adherence and lower HbA1c. However, uninsured and low-income populations may experience unique self-management challenges and have limited access to self-management supports.
Objectives
To assess the feasibility, acceptability, and preliminary effectiveness of a pharmacist-driven 6-month pilot intervention to support diabetes self-management behaviors utilizing text messages among uninsured and underinsured patients with uncontrolled diabetes.
Methods
Eligible participants were English or Spanish-speaking patients at a Federally Qualified Health Center in Northern Illinois who had poorly controlled type 2 diabetes (HbA1c > 7) and access to a smartphone. Participants' HbA1c was measured at enrollment and upon completion. Interactive and informational messages were sent to participants using a secure text-messaging application. Messages included explanations, encouragement, and problem-solving suggestions. Message frequency was tapered to withdraw support gradually. Message engagement was tracked within the text-messaging software.
Results
Electronic medical records identified 192 eligible patients with type 2 diabetes, of whom 76 consented to enroll in the intervention. Mean HbA1c at enrollment was 9.3%. Engagement with messages did not vary by demographic or clinical characteristics. Of 75 participants in the analytic sample, 60 completed the postintervention HbA1c measurement. Thirty-five (58.3%) had clinically significant reductions in their HbA1c, and 16 (26.7%) reduced their HbA1c to under 7%, which is considered controlled. Smaller groups saw either HbA1c decreases of less than 0.5% (n = 8, 13.3%), no change (n = 3, 5.0%), or increases (n = 14, 23.3%).
Conclusion
This feasible and low-cost pilot intervention utilizing pharmacist services helped a large portion of patients attain a clinically significant reduction in their HbA1c and contributed to some individuals achieving blood sugar control.
期刊介绍:
The Journal of the American Pharmacists Association is the official peer-reviewed journal of the American Pharmacists Association (APhA), providing information on pharmaceutical care, drug therapy, diseases and other health issues, trends in pharmacy practice and therapeutics, informed opinion, and original research. JAPhA publishes original research, reviews, experiences, and opinion articles that link science to contemporary pharmacy practice to improve patient care.